Singapore Institute of Advanced Medicine's Loss After Tax Widens in H1; Shares Plunge 15%

MT Newswires2024-10-30

Singapore Institute of Advanced Medicine (SGX:9G2) loss after tax and total comprehensive loss from continuing operations for the six moths ended June 30 widened 67% year over year to SG$16.2 million from SG$9.7 million, a filing with the Singapore Exchange said on Tuesday.

Revenue remained relatively unchanged at SG$8.1 million for the period despite increase in revenue from radiation therapy and medical oncology services.

Shares of the medical services company plunged nearly 15% in recent trading.

Price (SGD): S$67.60, Change: S$+0.39, Percent Change: +0.58%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment